{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:03:47Z","timestamp":1784124227777,"version":"3.55.0"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Rheumatic heart disease (RHD) remains a leading cause of cardiovascular morbidity and maternal mortality in pregnancy worldwide. Despite near-eradication in high-income countries, RHD continues to disproportionately affect young women in low- and middle-income regions, where delayed diagnosis, limited access to preventive care, and constrained availability of cardiac interventions contribute to adverse maternal and fetal outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To present contemporary evidence on the global burden, pathophysiology, detection, surgical and interventional management, of maternal and fetal outcomes of rheumatic heart disease in pregnancy, with principal emphasis on low-resource and endemic settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a structured narrative review of the existing literature using PubMed\/MEDLINE, Embase, Scopus, and the Cochrane Library, identifying observational cohorts, multicenter registries, randomized trials, systematic reviews, international clinical guidelines, and expert reviews published between January 2005 and May 2026. Studies were included if they reported on RHD epidemiology, screening and prophylaxis strategies, cardiac or obstetric outcomes, surgical or transcatheter interventions, valve prosthesis selection, anticoagulation management, or intrapartum and postpartum care during pregnancy. Evidence was narratively synthesized and organized by thematic domains relevant to pregnancy-associated risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>RHD accounts for the majority of acquired heart disease in pregnancy across endemic regions, with contemporary registries reporting that 30%\u201370% of cardiac disease complicating pregnancy is rheumatic in origin. Mitral stenosis predominates and is associated with high rates of maternal heart failure, arrhythmia, thromboembolism, and postpartum decompensation. Maternal adverse cardiac events occur in approximately 15%\u201340% of pregnancies, with mortality ranging from 1%\u201310% depending on lesion severity, rhythm status, and access to care. Fetal complications, including preterm birth, low birth weight, and pregnancy loss, are common and are exacerbated by severe stenotic disease and prosthetic valves. Screening studies demonstrate that many women with RHD are unaware of their diagnosis prior to pregnancy, while randomized evidence supports echocardiographic screening coupled with secondary antibiotic prophylaxis to reduce disease progression in early-stage RHD. Surgical and interventional management during pregnancy remains high-risk, particularly in women with mechanical heart valves, underscoring the importance of preconception optimization and multidisciplinary care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Rheumatic heart disease in pregnancy confers substantial and preventable risk to both mother and fetus, particularly in low-resource settings where disease is often advanced at presentation. Improved strategies for early detection, primary and secondary prophylaxis, preconception counseling, and timely referral for valve intervention are essential to reducing maternal and fetal morbidity and mortality. Strengthening health systems to deliver integrated cardio-obstetric care remains central to improving outcomes for women with RHD worldwide.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fsurg.2026.1838220","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:05:29Z","timestamp":1784120729000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Global disparities in the detection and management of rheumatic heart disease in pregnancy across endemic settings"],"prefix":"10.3389","volume":"13","author":[{"given":"Emili","family":"Elkins","sequence":"first","affiliation":[{"name":"Structural Heart and Valve Center, New York Presbyterian Hospital-Columbia University Medical Center","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Gosden","sequence":"additional","affiliation":[{"name":"Structural Heart and Valve Center, New York Presbyterian Hospital-Columbia University Medical Center","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Ascione","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Foundation","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Reisinger","sequence":"additional","affiliation":[{"name":"University of Vermont Medical Center","place":["Burlington, VT, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Kachel","sequence":"additional","affiliation":[{"name":"Center for Cardiovascular Research and Development, American Heart of Poland","place":["Katowice, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Overtchouk","sequence":"additional","affiliation":[{"name":"Medniscient AI","place":["Dallas, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Haythe","sequence":"additional","affiliation":[{"name":"Division of Cardiology, New York Presbyterian Hospital-Columbia University Medical Center","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"George","sequence":"additional","affiliation":[{"name":"Structural Heart and Valve Center, New York Presbyterian Hospital-Columbia University Medical Center","place":["New York, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.122.028921","article-title":"Global, regional, and national advances toward the management of rheumatic heart disease based on the global burden of disease study 2019","volume":"12","author":"Ruan","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"B2","doi-asserted-by":"publisher","first-page":"552","DOI":"10.5152\/anatoljcardiol.2022.1644","article-title":"Maternal and fetal outcomes following percutaneous transluminal mitral commissurotomy in pregnant women with critical mitral stenosis: an experience of a tertiary care center from northern India","volume":"26","author":"Vijayvergiya","year":"2022","journal-title":"Anatol J Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.jacc.2023.08.022","article-title":"Risk estimation in valvular heart disease in pregnancy","volume":"82","author":"Sharma","year":"2023","journal-title":"J Am C Cardiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/1471-0528.15938","article-title":"The high prevalence and impact of rheumatic heart disease in pregnancy in first nations populations in a high-income setting: a prospective cohort study","volume":"127","author":"Sullivan","year":"2019","journal-title":"BJOG"},{"key":"B5","doi-asserted-by":"publisher","first-page":"101368","DOI":"10.1016\/j.jacadv.2024.101368","article-title":"Global disparities in outcomes of pregnant individuals with rheumatic heart disease","volume":"3","author":"Yang","year":"2024","journal-title":"JACC Adv"},{"key":"B6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.5830\/cvja-2016-008","article-title":"The importance of cardiovascular pathology contributing to maternal death: confidential enquiry into maternal deaths in South Africa, 2011\u20132013","volume":"27","author":"Soma-Pillay","year":"2016","journal-title":"Cardiovasc J Afr"},{"key":"B7","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1161\/circulationaha.117.032561","article-title":"Pregnancy outcomes in women with rheumatic mitral valve disease","volume":"137","author":"van Hagen","year":"2018","journal-title":"Circulation"},{"key":"B8","volume-title":"Rheumatic Fever and Rheumatic Heart Disease: Report of a wHO Expert Consultation","year":""},{"key":"B9","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/S0140-6736(97)03317-5","article-title":"Effectiveness of clinical guidelines for the presumptive treatment of streptococcal pharyngitis in Egyptian children","volume":"350","author":"Steinhoff","year":"1997","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0020-7292(02)00029-2","article-title":"Maternal and perinatal outcome in rheumatic heart disease","volume":"80","author":"Sawhney","year":"2003","journal-title":"Int J Gynecol Obstet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2022.104293","article-title":"Pregnancy with heart disease in south Asia: a systematic review and meta-analysis of prevalence and outcome","volume":"80","author":"Shrestha","year":"2022","journal-title":"Ann Med Surg"},{"key":"B12","doi-asserted-by":"publisher","first-page":"394","DOI":"10.5830\/cvja-2018-044","article-title":"The pan-African society of cardiology position paper on reproductive healthcare for women with rheumatic heart disease","volume":"29","author":"Mocumbi","year":"2018","journal-title":"Cardiovasc J Afr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/eurheartj\/ehu449","article-title":"Characteristics, complications, and gaps in evidence-based interventions in rheumatic heart disease: the global rheumatic heart disease registry (the remedy study)","volume":"36","author":"Z\u00fchlke","year":"2014","journal-title":"Eur Heart J"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.120.016851","article-title":"Contemporary incidence and prevalence of rheumatic fever and rheumatic heart disease in Australia using linked data: the case for policy change","volume":"9","author":"Katzenellenbogen","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"B15","doi-asserted-by":"publisher","first-page":"980","DOI":"10.21037\/cdt-21-112","article-title":"Differences in socio-demographic and risk factor profile, clinical presentation, and outcomes between patients with and without RHD heart failure in sub-saharan Africa: results from the THESUS-HF registry","volume":"11","author":"Nkoke","year":"2021","journal-title":"Cardiovasc Diagn Ther"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2015.84","article-title":"Acute rheumatic fever and rheumatic heart disease","volume":"2","author":"Carapetis","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2021-007038","article-title":"Preceding group A streptococcus skin and throat infections are individually associated with acute rheumatic fever: evidence from New Zealand","volume":"6","author":"Oliver","year":"2021","journal-title":"BMJ Glob Health"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1447149","article-title":"A mini review of the pathogenesis of acute rheumatic fever and rheumatic heart disease","volume":"15","author":"Zhuang","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1056\/nejmoa1603693","article-title":"Global, regional, and national burden of rheumatic heart disease, 1990\u20132015","volume":"377","author":"Watkins","year":"2017","journal-title":"N Engl J Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3109\/08830185.2014.917411","article-title":"Rheumatic fever, autoimmunity, and molecular mimicry: the streptococcal connection","volume":"33","author":"Cunningham","year":"2014","journal-title":"Int Rev Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1365-3083.2007.01974.x","article-title":"Rheumatic fever and rheumatic heart disease: genetics and pathogenesis","volume":"66","author":"Guilherme","year":"2007","journal-title":"Scand J Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1161\/cir.0000000000000205","article-title":"Revision of the jones criteria for the diagnosis of acute rheumatic fever in the era of Doppler echocardiography","volume":"131","author":"Gewitz","year":"2015","journal-title":"Circulation"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.676938","article-title":"3D Echocardiography for rheumatic heart disease analysis: ready for prime time","volume":"8","author":"Vieira","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2014.00126","article-title":"Incidental histological diagnosis of acute rheumatic myocarditis: case report and review of the literature","volume":"2","author":"Sampaio","year":"2014","journal-title":"Front Pediatr"},{"key":"B25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.5334\/gh.1183","article-title":"Outcomes in pregnant women with valvular heart disease from Portuguese-speaking African countries treated in Portugal through an international agreement of health cooperation","volume":"18","author":"Ferreira","year":"2023","journal-title":"Glob Heart"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd002227","article-title":"Penicillin for secondary prevention of rheumatic fever","volume":"2013","author":"Manyemba","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1161\/circulationaha.109.191959","article-title":"Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis","volume":"119","author":"Gerber","year":"2009","journal-title":"Circulation"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1161\/cir.0000000000000923","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"B29","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1093\/eurheartj\/ehaf194","article-title":"2025 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"46","author":"Praz","year":"2025","journal-title":"Eur Heart J"},{"key":"B30","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41569-023-00940-9","article-title":"2023 World heart federation guidelines for the echocardiographic diagnosis of rheumatic heart disease","volume":"21","author":"Rwebembera","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00730-x","article-title":"Update on the development of group A streptococcus vaccines","volume":"8","author":"Ajay Castro","year":"2023","journal-title":"NPJ Vaccines"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2261-5-11","article-title":"Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis","volume":"5","author":"Robertson","year":"2005","journal-title":"BMC Cardiovasc Disord"},{"key":"B33","year":"2025"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.5935\/abc.20190141","article-title":"Rheumatic fever: a disease without color","volume":"113","author":"Figueiredo","year":"2019","journal-title":"Arq Bras Cardiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(13)62004-5","article-title":"Access to essential medicines: illuminating disparities in the global supply of BENZATHINE penicillin G in the context of rheumatic fever\/rheumatic heart disease prevention","volume":"61","author":"Taubert","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.gheart.2013.08.011","article-title":"Benzathine penicillin G for the management of RHD: concerns about quality and access, and opportunities for intervention and improvement","volume":"8","author":"Wyber","year":"2013","journal-title":"Glob Heart"},{"key":"B37","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/inthealth\/ihad087","article-title":"Securing the supply of benzathine penicillin: a global perspective on risks and mitigation strategies to prevent future shortages","volume":"16","author":"Seghers","year":"2024","journal-title":"Int Health"},{"key":"B38","volume-title":"World Health Organization. Rheumatic Heart Disease","year":""},{"key":"B39","first-page":"1394","article-title":"Resource utilization and cost of rheumatic fever","volume":"28","author":"Terreri","year":"2001","journal-title":"J Rheumatol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"265","DOI":"10.31128\/ajgp-02-21-5852","article-title":"Primary prevention of acute rheumatic fever","volume":"50","author":"Wyber","year":"2021","journal-title":"Aust J Gen Pract"},{"key":"B41","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1097\/inf.0000000000002770","article-title":"School-based streptococcal a sore-throat treatment programs and acute rheumatic fever amongst Indigenous m\u0101ori: a retrospective cohort study","volume":"39","author":"Walsh","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2023-012356","article-title":"Research opportunities for the primary prevention and management of acute rheumatic fever and rheumatic heart disease: a national heart, lung, and blood institute workshop report","volume":"8","author":"Rwebembera","year":"2023","journal-title":"BMJ Glob Health"},{"key":"B43","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/jpc.16797","article-title":"Missed opportunities for preventing or diagnosing acute rheumatic fever: a retrospective cohort study of 20 young Australians diagnosed with rheumatic heart disease on screening echocardiography","volume":"61","author":"Rouhiainen","year":"2025","journal-title":"J Paediatr Child Health"},{"key":"B44","first-page":"881","article-title":"Acute rheumatic fever in first nations communities in northwestern Ontario: social determinants of health \u201cbite the heart\u201d","volume":"61","author":"Gordon","year":"2015","journal-title":"Can Fam Physician"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53540-4","article-title":"Prevalence and progression of rheumatic heart disease: a global systematic review and meta-analysis of population-based echocardiographic studies","volume":"9","author":"Noubiap","year":"2019","journal-title":"Sci Rep"},{"key":"B46","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1136\/heartjnl-2018-313810","article-title":"Impact of heart disease on maternal, fetal and neonatal outcomes in a low-resource setting","volume":"105","author":"Beaton","year":"2019","journal-title":"Heart"},{"key":"B47","doi-asserted-by":"publisher","first-page":"39","DOI":"10.5334\/gh.1318","article-title":"Routine antenatal echocardiography in high-prevalence areas of rheumatic heart disease: a WHO-guideline systematic review","volume":"19","author":"Seitler","year":"2024","journal-title":"Glob Heart"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1017\/s1047951115001857","article-title":"Evaluation of a focussed protocol for hand-held echocardiography and computer-assisted auscultation in detecting latent rheumatic heart disease in scholars","volume":"26","author":"Z\u00fchlke","year":"2015","journal-title":"Cardiol Young"},{"key":"B49","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/nejmoa2102074","article-title":"Secondary antibiotic prophylaxis for latent rheumatic heart disease","volume":"386","author":"Beaton","year":"2022","journal-title":"N Engl J Med"},{"key":"B50","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jamacardio.2020.7050","article-title":"Effectiveness of systematic echocardiographic screening for rheumatic heart disease in Nepalese schoolchildren","volume":"6","author":"Karki","year":"2021","journal-title":"JAMA Cardiol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-023-03186-y","article-title":"Sub-clinical rheumatic heart disease (RHD) detected by hand-held echocardiogram in children participating in a school-based RHD prevention program in Tanzania","volume":"23","author":"Chillo","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1093\/eurheartj\/ehad003","article-title":"Pregnancy outcomes in women with heart disease: the madras medical college pregnancy and cardiac (M-PAC) registry from India","volume":"44","author":"Justin Paul","year":"2023","journal-title":"Eur Heart J"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1136\/heartjnl-2020-316648","article-title":"Prediction of adverse cardiac events in pregnant women with valvular rheumatic heart disease","volume":"106","author":"Baghel","year":"2020","journal-title":"Heart"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1136\/heartjnl-2014-306199","article-title":"Spectrum of cardiac disease in maternity in a low-resource cohort in South Africa","volume":"100","author":"Sliwa","year":"2014","journal-title":"Heart"},{"key":"B55","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/ajo.13559","article-title":"Rheumatic heart disease in pregnancy: maternal and neonatal outcomes in the top End of Australia","volume":"63","author":"Lam","year":"2023","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"4462","DOI":"10.1093\/eurheartj\/ehaf193","article-title":"2025 ESC guidelines for the management of cardiovascular disease and pregnancy","volume":"46","author":"De Backer","year":"2025","journal-title":"Eur Heart J"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e337","DOI":"10.1161\/CIR.0000000000000921","article-title":"Contemporary diagnosis and management of rheumatic heart disease: implications for closing the gap: a scientific statement from the American Heart Association","volume":"142","author":"Kumar","year":"2020","journal-title":"Circulation"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1093\/eurheartj\/ehaf265","article-title":"Pregnancy with a prosthetic heart valve, thrombosis, and bleeding: the ESC EORP registry of pregnancy and cardiac disease III","volume":"47","author":"van der Zande","year":"2026","journal-title":"Eur Heart J"},{"key":"B59","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.ahj.2024.04.002","article-title":"Comparing the outcomes of rheumatic heart disease in pregnancy complicated with and without atrial fibrillation: a propensity score matched analysis","volume":"273","author":"Keepanasseril","year":"2024","journal-title":"Am Heart J"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e657","DOI":"10.1161\/CIR.0000000000001121","article-title":"Anesthetic care of the pregnant patient with cardiovascular disease: a scientific statement from the American Heart Association","volume":"147","author":"Meng","year":"2023","journal-title":"Circulation"},{"key":"B61","doi-asserted-by":"publisher","first-page":"100901","DOI":"10.1016\/j.jacadv.2024.100901","article-title":"Recommendations for the management of high-risk cardiac delivery: aCC cardiovascular disease in women committee panel","volume":"3","author":"Lau","year":"2024","journal-title":"JACC Adv"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e20240807","DOI":"10.36660\/abc.20240807i","article-title":"REBECGA: brazilian registry of heart disease and pregnancy. Multicenter epidemiological study of heart diseases in pregnancy: retrospective cohort","volume":"122","author":"Avila","year":"2025","journal-title":"Arq Bras Cardiol"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2026.1838220\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:05:30Z","timestamp":1784120730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2026.1838220\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":62,"alternative-id":["10.3389\/fsurg.2026.1838220"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2026.1838220","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"article-number":"1838220"}}